The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma

Clinical and Experimental Allergy

Volumn 29, Issue 1, 1999, Pages 42-51

  Diamant, Z ^a   Grootendorst, D C ^a   Veselic Charvat, M ^a   Timmers, M C ^a   De Smet, M ^b   Leff, J A ^b   Seidenberg, B C ^b   Zwinderman, A H ^a   Peszek, I ^b   Sterk, P J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bronchial provocation tests; Eosinophil cationic protein; Eosinophils; Leukotriene receptor antagonist; Sputum

Indexed keywords

HISTAMINE PHOSPHATE; HOUSE DUST ALLERGEN; MONTELUKAST; PEPTIDOLEUKOTRIENE; PLACEBO;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL COUNT; CHEMOTAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

ACETATES; ADULT; ALLERGENS; ANTI-ASTHMATIC AGENTS; ASTHMA; BLOOD PROTEINS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CELL COUNT; CELL SURVIVAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EOSINOPHIL GRANULE PROTEINS; FORCED EXPIRATORY VOLUME; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; LEUKOTRIENE ANTAGONISTS; MALE; PATIENT COMPLIANCE; QUINOLINES; RIBONUCLEASES; SPUTUM; TREATMENT OUTCOME;

EID: 0032950143     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00447.x     Document Type: Article

References (38)

1. 1 Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol 1994; 12:295-335.
2. 2 Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323:645-55.
3. 3 Rabe KF, Munoz NM, Vita AJ, Morton BE, Magnussen H, Leff AR. Contraction of human bronchial smooth muscle caused by activated human eosinophils. Am J Physiol 1994; 267: 1326-34.
4. 4 Crooke ST, Mattern M, Sarau HM, et al. The signal transduction system of the leukotriene D4 receptor. Trends Pharmacol Sci 1989; 10:103-7.
5. 4 and to methacholine in patients with asthma and normal controls. N Engl J Med 1986; 315:480-4.
6. 6 O'Hickey SP, Hawksworth RJ, Fong CY, Arm JP, Spur BW, Lee TH. Leukotrienes C4, D4 and E4 enhance histamine responsiveness in asthmatic airways. Am Rev Respir Dis 1991; 144:1053-7.
7. 7 Bel EH, van der Veen H, Kramps JA, Dijkman JH, Sterk PJ. Maximal airway narrowing to inhaled leukotriene D4 in normal subjects: comparison and interaction with methacholine. Am Rev Respir Dis 1987; 136:979-84.
8. 4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994; 55:183-91.
9. 9 Foster A, Chan CC. Peptide leukotriene involvement in pulmonary eosinophil migration upon challenge in the actively sensitized guinea pig. Int Arch Allergy Immunol 1991; 96:279-84.
10. 4 and granulocytic infiltration into asthmastic airways. Lancet 1993; 341:989-90.
11. 4 and methacholine on cell differentials in sputum from patients with asthma. Am J Respir Crit Care Med 1997; 155:1247-53.
12. 12 Diamant Z, Lammers J-WJ, Sterk PJ. Leukotriene receptor antagonists and biosynthesis inhibitors in asthma an update. Clin Immunother 1994; 2:220-32.
13. 13 Calhoun WJ, Williams KL, Simonson SG, Lavins BJ. Effect of zafirlukast (Accolate) on airway inflammation after segmental allergen challenge in patients with mild asthma. Am J Respir Crit Care Med 1997; 155:A662. (Abstr.)
14. 14 Pin I, Freitag AP, O'Byrne PM et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145:1265-9.
15. 15 Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994; 93:1031-9.
16. 16 Gauvreau GM, Doctor J, Watson RM, Jordana M, O'Byrne PM. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996; 154:1267-71.
17. 17 Schoors DF, De Smet M, Reiss T et al. Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers. Br J Clin Pharmacol 1995; 40:277-80.
18. 4-receptor antagonist exhibits a dose response in the inhibition of exercise induced bronchoconstriction at the end of a once daily dosing interval. J Invest Med 1995; 43:275A (Abstr.).
19. 19 Global initiative for asthma. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA, January 1995; (Publication no.) 95-3659.
20. 20 Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 (Suppl. 16):5-40.
21. 21 Sterk PJ, Fabbri LM, Quanjer PhH et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993; 6 (Suppl.16):53-83.
22. 22 Cockcroft DW, Murdock KY, Kirby JG, Hargreave FE. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987; 135:264-7.
23. 23 Durham SR. The significance of late responses in asthma. Clin Exp Allergy 1991; 21:3-7.
24. 24 Söderberg M, Lundgren R, Bjermer L, Stjernberg N, Rosenhall L. Inflammatory response in bronchoalveolar lavage fluid after inhaling histamine. Allergy 1988; 43:98-102.
25. 25 Diamant Z, Timmers MC, Van der Veen H et al. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 1995; 95:42-51.
26. 26 In't Veen JC, Wendt GG, Hiemstra PS, Sterk PJ, Bel EH. Repeatability of cellular and soluble markers in induced sputum of patients with asthma. Eur Respir J 1996; 9:2441-7.
27. 27 Grootendorst DC, Sont JK, Willems LNA et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy 1997; 27:769-79.
28. 28 Inman MD, Watson R, Cockcroft DW, Wong BJO, Hargreave FE, O'Byrne PM. Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol 1995; 95:1191-5.
29. 29 Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991; 337:690-4.
30. 4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. J Allergy Clin Immunol 1992; 90:193-201.
31. 31 O'Byrne PM, Dolovich J, Hargreave FE. State of art: late asthmatic responses. Am Rev Respir Dis 1987; 136:740-51.
32. 32 Diaz P, Gonzalez MC, Galleguillos FR et al. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989; 139:1383-9.
33. 33 Weersink EJM, Postma DS, Aalbers R, De Monchy JG. Early and late asthmatic reaction after allergen challenge. Respir Med 1994; 88:103-14.
34. 34 Gratziou C, Carroll M, Montefort S, Teran L, Howarth PH, Holgate ST. Inflammatory and T-cell profile of asthmatic airways 6 hours after local allergen provocation. Am J Respir Crit Care Med 1996; 153:515-20.
35. 35 Kane GC, Pollice M, Kim C-J et al. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. J Allergy Clin Immunol 1996; 97:646-54.
36. 36 Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ, Westcott JY. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152:897-905.
37. 37 Pizzichini MMM, Kidney JC, Wong BJO et al. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Eur Respir J 1996; 9:449-55.
38. 38 Leff JA, Pizzichini E, Efthimiadis A et al. Effect of montelukast (MK-0476) on airway eosinophilic inflammation in mildly uncontrolled asthma: a randomized, placebo-controlled trial. Am J Respir Crit Care Med 1997; 155:A977 (Abstr.).